10.69

0.09% -0.010

After Hours: 10.69

Fennec Pharmaceuticals Inc (FENC)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Fennec Pharmaceuticals Inc stock is traded at $10.69, with a volume of 150.65K. It is down -0.09% in the last 24 hours and up +22.87% over the past month. Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.

Previous Close:

$10.70

Open:

$10.67

24h Volume:

150.65K

Relative Volume:

0.57

Market Cap:

$371.34M

Revenue:

$51.00M

Net Income/Loss:

$-8.73M

P/E Ratio:

-36.09

EPS:

-0.2962

Net Cash Flow:

$-7.75M

1W Performance:

-3.08%

1M Performance:

+22.87%

6M Performance:

+44.85%

1Y Performance:

+21.48%

1-Day Range:

$10.50

$10.95

1-Week Range:

$10.21

$11.21

52-Week Range:

$5.65

$11.31

Fennec Pharmaceuticals Inc Stock (FENC) Company Profile

Name

Fennec Pharmaceuticals Inc

Sector

Healthcare (1100)

Industry

Biotechnology (615)

Phone

(919) 636-4530

Address

PO BOX 13628, RESEARCH TRIANGLE PARK, NC

Employee

Twitter

@FennecPharma

Next Earnings Date

2026-08-13

Latest SEC Filings

FENC's Discussions on Twitter

Compare FENC vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
FENC Fennec Pharmaceuticals Inc	10.69	373.42M	51.00M	-8.73M	-7.75M	-0.2962
VRTX Vertex Pharmaceuticals Inc	529.59	126.07B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	649.81	65.37B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	916.80	57.70B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	313.04	40.19B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	189.99	39.82B	742.00K	-1.37B	-1.07B	-7.0731

Fennec Pharmaceuticals Inc Stock (FENC) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-12-26	Initiated	B. Riley Securities	Buy
Jan-09-26	Initiated	Piper Sandler	Overweight
Nov-22-22	Upgrade	Cantor Fitzgerald	Neutral → Overweight
Sep-07-22	Initiated	CapitalOne	Overweight
Aug-08-22	Resumed	Craig Hallum	Buy
Jun-05-20	Initiated	Cantor Fitzgerald	Overweight
Oct-11-18	Initiated	Goldman	Buy

View All

Fennec Pharmaceuticals Inc Stock (FENC) Latest News

Jul 01, 2026

Form 144 FENNEC PHARMACEUTICALS INC. For: 1 July By Investing.com - Investing.com India

Jul 01, 2026

Fennec Pharmaceuticals (FENC) CCO receives 168-share award, holds 21,183 - Stock Titan

Jul 01, 2026

Fennec (NASDAQ: FENC) CMO awarded 168 shares, holds 21,183 - Stock Titan

Jul 01, 2026

Fennec Pharmaceuticals (NASDAQ: FENC) CEO reports 1,159-share award release - Stock Titan

Jul 01, 2026

FENNEC (FENC) CFO Andrade gains 1,703 vested shares, now holds 290,972 - Stock Titan

Jul 01, 2026

Fennec (NASDAQ: FENC) Chief Strategy Officer receives 156-share stock award - Stock Titan

Jul 01, 2026

FENC (NASDAQ: FENC) plans 9,599-share option sale; prior small sales listed - Stock Titan

Jul 01, 2026

Jun 29, 2026

Fennec Pharmaceuticals Inc.(NasdaqCM:FENC) dropped from Russell 2000 Value Benchmark - marketscreener.com

Jun 29, 2026

Fennec Pharmaceuticals Inc.(NasdaqCM:FENC) dropped from Russell Microcap Value Benchmark Index - marketscreener.com

Jun 29, 2026

Jun 28, 2026

Fennec Pharmaceuticals Inc.(NasdaqCM:FENC) dropped from Russell 2500 Value Benchmark - marketscreener.com

Jun 28, 2026

Jun 27, 2026

Enterprise value to EBITDA forward of Fennec Pharmaceuticals Inc. – NASDAQ:FENC - TradingView

Jun 27, 2026

Enterprise value to EBIT forward of Fennec Pharmaceuticals Inc. – NASDAQ:FENC - TradingView

Jun 27, 2026

Fennec Pharmaceuticals Hits Day High with 13.96% Surge in Stock Price - MarketsMojo

Jun 27, 2026

Enterprise value to EBIT forward of Fennec Pharmaceuticals Inc. – FWB:RV41 - TradingView

Jun 27, 2026

Enterprise value to EBITDA forward of Fennec Pharmaceuticals Inc. – FWB:RV41 - TradingView

Jun 27, 2026

Jun 26, 2026

Price to earnings forward of Fennec Pharmaceuticals Inc. – NASDAQ:FENC - TradingView

Jun 26, 2026

Fennec Pharmaceuticals Inc. Actuals & Estimates (TSX:FRX) - TradingView

Jun 26, 2026

RV41 Forecast — Price Target — Prediction for 2027 - TradingView

Jun 26, 2026

Price to sales forward of Fennec Pharmaceuticals Inc. – NASDAQ:FENC - TradingView

Jun 26, 2026

Jun 25, 2026

Price to book forward of Fennec Pharmaceuticals Inc. – NASDAQ:FENC - TradingView

Jun 25, 2026

Fennec Pharmaceuticals Inc. Actuals & Estimates (LS:A12A5F) - TradingView

Jun 25, 2026

Enterprise value to revenue forward of Fennec Pharmaceuticals Inc. – NASDAQ:FENC - TradingView

Jun 25, 2026

Price to earnings forward of Fennec Pharmaceuticals Inc. – BOATS:FENC - TradingView

Jun 25, 2026

Enterprise value to EBIT forward of Fennec Pharmaceuticals Inc. – BOATS:FENC - TradingView

Jun 25, 2026

Jun 24, 2026

Why Fennec Pharmaceuticals Inc stock is skyrocketing today - Wealth Awesome

Jun 24, 2026

Jun 22, 2026

Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - The Manila Times

Jun 22, 2026

Jun 21, 2026

Precision Trading with Fennec Pharmaceuticals Inc. (FENC) Risk Zones - Stock Traders Daily

Jun 21, 2026

Jun 19, 2026

Why Fennec Pharmaceuticals Inc stock is tanking today - Wealth Awesome

Jun 19, 2026